-
2
-
-
0035857351
-
Osteoporosis prevention, diagnosis, and therapy
-
NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy
-
NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285:785-795.
-
(2001)
JAMA
, vol.285
, pp. 785-795
-
-
-
5
-
-
0036776241
-
Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women
-
DOI 10.1210/jc.2002-020275
-
Tannenbaum C, Clark J, Schwartzman K, et al. Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. J Clin Endocrinol Metab. 2002;87:4431-4437. (Pubitemid 35247019)
-
(2002)
Journal of Clinical Endocrinology and Metabolism
, vol.87
, Issue.10
, pp. 4431-4437
-
-
Tannenbaum, C.1
Clark, J.2
Schwartzman, K.3
Wallenstein, S.4
Lapinski, R.5
Meier, D.6
Luckey, M.7
-
6
-
-
79952394479
-
American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of postmenopausal osteoporosis
-
Watts N, Bilezikian J, Camacho P, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract. 2010;16 (Suppl 3):1-37.
-
(2010)
Endocr Pract
, vol.16
, Issue.SUPPL. 3
, pp. 1-37
-
-
Watts, N.1
Bilezikian, J.2
Camacho, P.3
-
8
-
-
1442278883
-
Exogenous Testosterone or Testosterone with Finasteride Increases Bone Mineral Density in Older Men with Low Serum Testosterone
-
DOI 10.1210/jc.2003-031110
-
Amory JK, Watts NB, Easley KA, et al. Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone. J Clin Endocrinol Metab. 2004;89:503-510. (Pubitemid 38269849)
-
(2004)
Journal of Clinical Endocrinology and Metabolism
, vol.89
, Issue.2
, pp. 503-510
-
-
Amory, J.K.1
Watts, N.B.2
Easley, K.A.3
Sutton, P.R.4
Anawalt, B.D.5
Matsumoto, A.M.6
Bremner, W.J.7
Tenover, J.L.8
-
9
-
-
0036316817
-
Osteopenia in exercise-associated amenorrhea using ballet dancers as a model: A longitudinal study
-
DOI 10.1210/jc.87.7.3162
-
Warren MP, Brooks-Gunn J, Fox RP, Holderness CC, Hyle EP, Hamilton WG. Osteopenia in exercise-associated amenorrhea using ballet dancers as a model: A longitudinal study. J Clin Endocrinol Metab. 2002;87:3162-3168. (Pubitemid 34816359)
-
(2002)
Journal of Clinical Endocrinology and Metabolism
, vol.87
, Issue.7
, pp. 3162-3168
-
-
Warren, M.P.1
Brooks-Gunn, J.2
Fox, R.P.3
Holderness, C.C.4
Hyle, E.P.5
Hamilton, W.G.6
-
10
-
-
0034700316
-
Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa
-
Grinspoon S, Thomas E, Pitts S, et al. Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann Intern Med. 2000;133:790-794.
-
(2000)
Ann Intern Med
, vol.133
, pp. 790-794
-
-
Grinspoon, S.1
Thomas, E.2
Pitts, S.3
-
11
-
-
0033774210
-
The physiology of the highly trained female endurance runner
-
Burrows M, Bird S. The physiology of the highly trained female endurance runner. Sports Med. 2000;30:281-300.
-
(2000)
Sports Med
, vol.30
, pp. 281-300
-
-
Burrows, M.1
Bird, S.2
-
12
-
-
0036738484
-
Abnormal bone mineral accrual in adolescent girls with anorexia nervosa
-
Soyka LA, Misra M, Frenchman A, et al. Abnormal bone mineral accrual in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab. 2002;87:4177-4185.
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 4177-4185
-
-
Soyka, L.A.1
Misra, M.2
Frenchman, A.3
-
13
-
-
77952828166
-
Anorexia nervosa, osteoporosis and circulating leptin: The missing link
-
Legroux I, Pigny B, Vignau J, et al. Anorexia nervosa, osteoporosis and circulating leptin: the missing link. Osteo International. 2010;21:1715-1722.
-
(2010)
Osteo International
, vol.21
, pp. 1715-1722
-
-
Legroux, I.1
Pigny, B.2
Vignau, J.3
-
14
-
-
0027051476
-
Osteoporosis in anorexia nervosa: The influence of peak bone density, bone loss, oral contraceptive use, and exercise
-
Seeman E, Szmukler GI, Formica C, Tsalamandris C, Mestrovic R. Osteoporosis in anorexia nervosa: the influence of peak bone density, bone loss, oral contraceptive use, and exercise. J Bone Miner Res. 1992;7:1467-1474. (Pubitemid 23007093)
-
(1992)
Journal of Bone and Mineral Research
, vol.7
, Issue.12
, pp. 1467-1474
-
-
Seeman, E.1
Szmukler, G.I.2
Formica, C.3
Tsalamandris, C.4
Mestrovic, R.5
-
15
-
-
79960082236
-
Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: A randomized, placebo-controlled study
-
Miller K, Meenaghan E, Lawson E, et al. Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: A randomized, placebo-controlled study. J Clin Endocrinol Metab. 2011;96:2081-2088.
-
(2011)
J Clin Endocrinol Metab
, vol.96
, pp. 2081-2088
-
-
Miller, K.1
Meenaghan, E.2
Lawson, E.3
-
16
-
-
77952115101
-
Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women
-
Gray S, LaCroix A, Larson J, et al. Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women. Arch Intern Med. 2010;170:765-771.
-
(2010)
Arch Intern Med
, vol.170
, pp. 765-771
-
-
Gray, S.1
LaCroix, A.2
Larson, J.3
-
18
-
-
7944235860
-
Fracture risk associated with use of antiepileptic drugs
-
DOI 10.1111/j.0013-9580.2004.18804.x
-
Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with use of epileptic drugs. Epilepsia. 2004;45:1330-1337. (Pubitemid 39470036)
-
(2004)
Epilepsia
, vol.45
, Issue.11
, pp. 1330-1337
-
-
Vestergaard, P.1
Rejnmark, L.2
Mosekilde, L.3
-
19
-
-
0029838671
-
Histomorphometric analysis of the effects of standard heparin on trabecular bone in vivo
-
Muir JM, Andrew M, Hirsh J. et al. Histomorphometric analysis of the effects of standard heparin on trabecular bone in vivo. Blood. 1996;88:1314-1320. (Pubitemid 26276806)
-
(1996)
Blood
, vol.88
, Issue.4
, pp. 1314-1320
-
-
Muir, J.M.1
Andrew, M.2
Hirsh, J.3
Weitz, J.I.4
Young, E.5
Deschamps, P.6
Shaughnessy, S.G.7
-
20
-
-
0027467168
-
Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin
-
Dahlman TC. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 1894 women undergoing thromboprophylaxis with heparin. Am J Obstet Gynecol. 1993;168:1265-1270. (Pubitemid 23122178)
-
(1993)
American Journal of Obstetrics and Gynecology
, vol.168
, Issue.4
, pp. 1265-1270
-
-
Dahlman, T.C.1
-
22
-
-
0034094875
-
Use of oral corticosteroids and risk of fractures
-
van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C. Use of oral corticosteroids and risk of fractures. J Bone Miner Res. 2000;15:993-1000. (Pubitemid 30350061)
-
(2000)
Journal of Bone and Mineral Research
, vol.15
, Issue.6
, pp. 993-1000
-
-
Van Staa, T.P.1
Leufkens, H.G.M.2
Abenhaim, L.3
Zhang, B.4
Cooper, C.5
-
23
-
-
0025101215
-
Glucocorticoid-induced osteoporosis: Pathogenesis and management
-
Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med. 1990;112:352-364. (Pubitemid 20083611)
-
(1990)
Annals of Internal Medicine
, vol.112
, Issue.5
, pp. 352-364
-
-
Lukert, B.P.1
Raisz, L.G.2
-
24
-
-
0031787349
-
Corticosteroid-induced bone loss in men
-
DOI 10.1210/jc.83.3.801
-
Pearce G, Tabensky DA, Delmas PD, Baker HW, Seeman E. Corticosteroid-induced bone loss in men. J Clin Endocrinol Metab. 1998;83:801-806. (Pubitemid 28496450)
-
(1998)
Journal of Clinical Endocrinology and Metabolism
, vol.83
, Issue.3
, pp. 801-806
-
-
Pearce, G.1
Tabensky, D.A.2
Delmas, P.D.3
Baker, H.W.G.4
Seeman, E.5
-
25
-
-
18244431006
-
Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis
-
DOI 10.1056/NEJM199807303390502
-
Saag K, Emkey R, et al. The Glucocorticoid-Induced Osteoporosis Intervention Study Group. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. N Eng J Med. 1998; 339:292-299. (Pubitemid 28366417)
-
(1998)
New England Journal of Medicine
, vol.339
, Issue.5
, pp. 292-299
-
-
Saag, K.G.1
Emkey, R.2
Schnitzer, T.J.3
Brown, J.P.4
Hawkins, F.5
Goemaere, S.6
Thamsborg, G.7
Liberman, U.A.8
Delmas, P.D.9
Malice, M.-P.10
Czachur, M.11
Daifotis, A.G.12
Lane, N.13
Correa-Rotter, R.14
Yanover, M.15
Westhovens, R.16
Epstein, S.17
Adachi, J.D.18
Poubelle, P.19
Melo-Gomes, J.20
Rodriguez-Portales, J.A.21
more..
-
26
-
-
0033498501
-
Risedronate therapy prevents corticosteroid-induced bone loss: A twelve month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study
-
Cohen S, Levy RM, Keller M, et al. Risedronate therapy prevents corticosteroid-induced bone loss: a twelve month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Arthritis Rheum. 1999;42:2309-1238.
-
(1999)
Arthritis Rheum
, vol.42
, pp. 2309-11238
-
-
Cohen, S.1
Levy, R.M.2
Keller, M.3
-
27
-
-
64049104797
-
Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): A multicenter, double-blind, double-dummy, randomized controlled trial
-
Reid DM, Devogelaer JP, Saag K, et al. Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicenter, double-blind, double-dummy, randomized controlled trial. Lancet. 2009;373:1253-1263.
-
(2009)
Lancet
, vol.373
, pp. 1253-1263
-
-
Reid, D.M.1
Devogelaer, J.P.2
Saag, K.3
-
28
-
-
36148958951
-
Teriparatide or alendronate in glucocorticoid-induced osteoporosis
-
DOI 10.1056/NEJMoa071408
-
Saag KG, Shane E, Boonen, S, et al. Teriparatide or alendronate in glucocorticoid-induced osteoporosis. N Engl J Med. 2007;357:2028-2039. (Pubitemid 350106710)
-
(2007)
New England Journal of Medicine
, vol.357
, Issue.20
, pp. 2028-2039
-
-
Saag, K.G.1
Shane, E.2
Boonen, S.3
Marin, F.4
Donley, D.W.5
Taylor, K.A.6
Dalsky, G.P.7
Marcus, R.8
-
29
-
-
79951581065
-
American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis
-
Grossman J, Gordon R, Ranganath V, et al. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken). 2010;62:1515-1526.
-
(2010)
Arthritis Care Res (Hoboken)
, vol.62
, pp. 1515-1526
-
-
Grossman, J.1
Gordon, R.2
Ranganath, V.3
-
30
-
-
80052007833
-
Uncertainties in the prevention and treatment of glucocorticoid-induced osteoporosis
-
Hansen KE, Wilson HA, Zapalowski C, Fink HA, Minisola S, Adler RA. Uncertainties in the prevention and treatment of glucocorticoid-induced osteoporosis. J Bone Miner Res. 2011;26:1989-1996.
-
(2011)
J Bone Miner Res
, vol.26
, pp. 1989-1996
-
-
Hansen, K.E.1
Wilson, H.A.2
Zapalowski, C.3
Fink, H.A.4
Minisola, S.5
Adler, R.A.6
-
31
-
-
34248169161
-
Initial hormonal management of Androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 Update of an American society of clinical oncology practice guideline
-
DOI 10.1200/JCO.2006.10.1949
-
Loblaw DA, Virgo KS, Nam R, et al. Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2007 Update of an American Society of Clinical Oncology Practice Guideline. J Clin Oncol. 2007;25:1596-1605. (Pubitemid 46733088)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.12
, pp. 1596-1605
-
-
Loblaw, D.A.1
Virgo, K.S.2
Nam, R.3
Somerfield, M.R.4
Ben-Josef, E.5
Mendelson, D.S.6
Middleton, R.7
Sharp, S.A.8
Smith, T.J.9
Talcott, J.10
Taplin, M.11
Vogelzang, N.J.12
Wade III, J.L.13
Bennett, C.L.14
Scher, H.I.15
-
32
-
-
11844252588
-
Risk of fracture after androgen deprivation for prostate cancer
-
DOI 10.1056/NEJMoa041943
-
Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med. 2005;352:154-164. (Pubitemid 40096612)
-
(2005)
New England Journal of Medicine
, vol.352
, Issue.2
, pp. 154-164
-
-
Shahinian, V.B.1
Kuo, Y.-F.2
Freeman, J.L.3
Goodwin, J.S.4
-
33
-
-
33947732766
-
Effect of once-weekly oral alendronate on bone loss in men receiving androgen deprivation therapy for prostate cancer: A randomized trial
-
Greenspan SL, Nelson JB, Trump DL, Resnick NM. Effect of once-weekly oral alendronate on bone loss in men receiving androgen deprivation therapy for prostate cancer. Ann Int Med. 2007;146:416-424. (Pubitemid 351650576)
-
(2007)
Annals of Internal Medicine
, vol.146
, Issue.6
, pp. 416-424
-
-
Greenspan, S.L.1
Nelson, J.B.2
Trump, D.L.3
Resnick, N.M.4
Miller, M.5
-
34
-
-
34047237418
-
Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer
-
DOI 10.1200/JCO.2006.07.3361
-
Michaelson M, Kaufman D, Lee H, et al. Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer. J Clin Oncol. 2007;25:1038-1042. (Pubitemid 46596753)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.9
, pp. 1038-1042
-
-
Michaelson, M.D.1
Kaufman, D.S.2
Lee, H.3
McGovern, F.J.4
Kantoff, P.W.5
Fallon, M.A.6
Finkelstein, J.S.7
Smith, M.R.8
-
35
-
-
69049105440
-
Denosumab in men receiving androgen-deprivation therapy for prostate cancer
-
Smith MR, Egerdie B, Hernández Toriz N, et al. Denosumab in men receiving androgen-deprivation therapy for prostate cancer. N Engl J Med. 2009;361:745-755.
-
(2009)
N Engl J Med
, vol.361
, pp. 745-755
-
-
Smith, M.R.1
Egerdie, B.2
Hernández Toriz, N.3
-
36
-
-
77956635018
-
Fracture types and risk factors in men with prostate cancer on androgen deprivation therapy: A matched cohort study of 19,079 men
-
Alibhai SM, Duong-Hua M, Cheung AM, et al. Fracture types and risk factors in men with prostate cancer on androgen deprivation therapy: A matched cohort study of 19,079 men. J Urol. 2010;184:918-924.
-
(2010)
J Urol
, vol.184
, pp. 918-924
-
-
Alibhai, S.M.1
Duong-Hua, M.2
Cheung, A.M.3
-
37
-
-
0037157603
-
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: First results of the ATAC randomised trial
-
DOI 10.1016/S0140-6736(02)09088-8
-
Baum M, Budzar AU, Cuzick J, et al. Anastrazole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomized trial. Lancet. 2002;359:2131-2139. (Pubitemid 34694019)
-
(2002)
Lancet
, vol.359
, Issue.9324
, pp. 2131-2139
-
-
Baum, M.1
Buzdar, A.U.2
Cuzick, J.3
Forbes, J.4
Houghton, J.5
Klijn, J.G.M.6
Sahmoud, T.7
-
38
-
-
33947524592
-
Zoledronic acid inhibits adjuvant letrozole-induced bone loss in postmenopausal women with early breast cancer
-
Brufsky A, Harker WG, Beck JT, et al. Zoledronic acid inhibits adjuvant letrozole-induced bone loss in postmenopausal women with early breast cancer. J Clin Oncol. 2007;25:829.
-
(2007)
J Clin Oncol
, vol.25
, pp. 829
-
-
Brufsky, A.1
Harker, W.G.2
Beck, J.T.3
-
39
-
-
39749155815
-
Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: ZO-FAST Study results
-
Bundred NJ, Campbell ID, Davidson N, et al. Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: ZO-FAST Study results. Cancer. 2008;112:1001.
-
(2008)
Cancer
, vol.112
, pp. 1001
-
-
Bundred, N.J.1
Campbell, I.D.2
Davidson, N.3
-
40
-
-
77949900992
-
Prevention of aromatase inhibitor-induced bone loss using risedronate: The SABRE trial
-
Van Poznak C, Hannon RA, Mackey JR, et al. Prevention of aromatase inhibitor-induced bone loss using risedronate: the SABRE trial. J Clin Oncol. 2010;28:967-975.
-
(2010)
J Clin Oncol
, vol.28
, pp. 967-975
-
-
Van Poznak, C.1
Hannon, R.A.2
Mackey, J.R.3
-
41
-
-
54449084015
-
Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer
-
Ellis GK, Bone HG, Chlebowski R, et al. Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer. J Clin Oncol. 2008;26:4875-4882.
-
(2008)
J Clin Oncol
, vol.26
, pp. 4875-4882
-
-
Ellis, G.K.1
Bone, H.G.2
Chlebowski, R.3
-
42
-
-
78049526466
-
Use of repot medroxyprogesterone acetate and gracture risk
-
Meier C, Brauchli Y, Jick S, et al. Use of repot medroxyprogesterone acetate and gracture risk. J Clin Endocrinol Metab. 2010;95:4909-4916.
-
(2010)
J Clin Endocrinol Metab
, vol.95
, pp. 4909-4916
-
-
Meier, C.1
Brauchli, Y.2
Jick, S.3
-
44
-
-
0030774682
-
Bone loss in hyperthyroid patients and in former hyperthyroid patients controlled on medical therapy: Influence of aetiology and menopause
-
Jódar E, Muñoz-Torres M, Escobar-Jiménez F, Quesada-Charneco M, Lund del Castillo JD. Bone loss in hyperthyroid patients and in former hyperthyroid patients controlled on medical therapy: Influence of aetiology and menopause. Clin Endocrinol (Oxf). 1997;47:279-285. (Pubitemid 27395958)
-
(1997)
Clinical Endocrinology
, vol.47
, Issue.3
, pp. 279-285
-
-
Jodar, E.1
Munoz-Torres, M.2
Escobar-Jimenez, F.3
Quesada-Charneco, M.4
Luna, D.C.J.D.5
-
45
-
-
0036173697
-
4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)
-
DOI 10.1210/jc.87.2.489
-
Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4) and thyroid antibodies in the United States population (1988-1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87:489-499. (Pubitemid 34158210)
-
(2002)
Journal of Clinical Endocrinology and Metabolism
, vol.87
, Issue.2
, pp. 489-499
-
-
Hollowell, J.G.1
Staehling, N.W.2
Dana, F.W.3
Harry, H.W.4
Gunter, E.W.5
Spencer, C.A.6
Braverman, L.E.7
-
46
-
-
0034723754
-
The colorado thyroid disease prevalence study
-
Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160:526-534. (Pubitemid 30112276)
-
(2000)
Archives of Internal Medicine
, vol.160
, Issue.4
, pp. 526-534
-
-
Canaris, G.J.1
Manowitz, N.R.2
Mayor, G.3
Ridgway, E.C.4
-
47
-
-
79955666598
-
The thyroid epidemiology, audit, and research study (TEARS): Morbidity in patients with endogenous subclinical hyperthyroidism
-
Vadiveloo T, Donnan P, Cochrane L, Leese G. The thyroid epidemiology, audit, and research study (TEARS): Morbidity in patients with endogenous subclinical hyperthyroidism. J Clin Endocrinol Metab. 2011;96:1344-1351.
-
(2011)
J Clin Endocrinol Metab
, vol.96
, pp. 1344-1351
-
-
Vadiveloo, T.1
Donnan, P.2
Cochrane, L.3
Leese, G.4
-
48
-
-
0034534237
-
Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism
-
DOI 10.1210/jc.85.11.4157
-
Kumeda Y, Inaba M, Tahara H, et al. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism. J Clin Endocrinol Metab. 2000;85:4157-4161. (Pubitemid 32055367)
-
(2000)
Journal of Clinical Endocrinology and Metabolism
, vol.85
, Issue.11
, pp. 4157-4161
-
-
Kumeda, Y.1
Inaba, M.2
Tahara, H.3
Kurioka, Y.4
Ishikawa, T.5
Morii, H.6
Nishizawa, Y.7
-
49
-
-
21244465557
-
Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy
-
DOI 10.1210/jc.2004-2364
-
Holick MF, Siris ES, Binkley N, et al. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab. 2005;90:3215-3224. (Pubitemid 41014278)
-
(2005)
Journal of Clinical Endocrinology and Metabolism
, vol.90
, Issue.6
, pp. 3215-3224
-
-
Holick, M.F.1
Siris, E.S.2
Binkley, N.3
Beard, M.K.4
Khan, A.5
Katzer, J.T.6
Petruschke, R.A.7
Chen, E.8
De Papp, A.E.9
-
50
-
-
0034889433
-
Vitamin D deficiency and secondary hyperparathyroidism in the elderly: Consequences for bone loss and fractures and therapeutic implications
-
DOI 10.1210/er.22.4.477
-
Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001;22:477-501. (Pubitemid 32762324)
-
(2001)
Endocrine Reviews
, vol.22
, Issue.4
, pp. 477-501
-
-
Lips, P.1
-
51
-
-
0035048979
-
A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: Baseline data from the multiple outcomes of raloxifene evaluation clinical trial
-
DOI 10.1210/jc.86.3.1212
-
Lips P, Duong T, Oleksik A, et al. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: Baseline data from Multiple Outcomes of Raloxifene Evaluation clinical trial. J Clin Endocrinol Metab. 2001;86:1212-1221. (Pubitemid 32323007)
-
(2001)
Journal of Clinical Endocrinology and Metabolism
, vol.86
, Issue.3
, pp. 1212-1221
-
-
Lips, P.1
Duong, T.2
Oleksik, A.3
Black, D.4
Cummings, S.5
Cox, D.6
Nickelsen, T.7
-
52
-
-
79960104336
-
Endocrine Society Task Force. Evaluation, treatment, and prevention of vitamin D deficiency: An endocrine soci ety clinical practice guideline
-
Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Endocrine Society Task Force. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine soci ety clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911-1930.
-
(2011)
J Clin Endocrinol Metab
, vol.96
, pp. 1911-1930
-
-
Holick, M.F.1
Binkley, N.C.2
Bischoff-Ferrari, H.A.3
-
53
-
-
78650886291
-
The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know
-
Ross AC, Manson J, Abrams S, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96:53-58.
-
(2011)
J Clin Endocrinol Metab
, vol.96
, pp. 53-58
-
-
Ross, A.C.1
Manson, J.2
Abrams, S.3
-
54
-
-
0034279541
-
Skeletal effects of primary hyperparathyroidism
-
Syed Z, Khan A. Skeletal effects of primary hyperparathyroidism. Endocr Pract. 2000;6:385-388.
-
(2000)
Endocr Pract
, vol.6
, pp. 385-388
-
-
Syed, Z.1
Khan, A.2
-
55
-
-
0034713771
-
Primary hyperparathyroidism: Pathophysiology and impact on bone
-
Khan A, Bilezikian J. Primary hyperparathyroidism: Pathophysiology and impact on bone. CMAJ. 2000;163:184-187. (Pubitemid 30625659)
-
(2000)
Canadian Medical Association Journal
, vol.163
, Issue.2
, pp. 184-187
-
-
Khan, A.1
Bilezikian, J.2
-
56
-
-
0036925217
-
Summary statement from a workshop on asymptomatic primary hyperparathyroidism: A perspective for the 21st century
-
DOI 10.1210/jc.2002-021370
-
Bilezikian JP, Potts JT Jr, Fuleihan G-H, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: A perspective for the 21st century. J Clin Endocrinol Metab. 2002;87:5353-5361. (Pubitemid 36034328)
-
(2002)
Journal of Clinical Endocrinology and Metabolism
, vol.87
, Issue.12
, pp. 5353-5361
-
-
Bilezikian, J.P.1
Potts Jr., J.T.2
El-Hajj, F.G.3
Kleerekoper, M.4
Neer, R.5
Peacock, M.6
Rastad, J.7
Silverberg, S.J.8
Udelsman, R.9
Wells, S.A.10
-
57
-
-
0033592750
-
A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery
-
DOI 10.1056/NEJM199910213411701
-
Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med. 1999;341:1249-1255. (Pubitemid 29489739)
-
(1999)
New England Journal of Medicine
, vol.341
, Issue.17
, pp. 1249-1255
-
-
Silverberg, S.J.1
Shane, E.2
Jacobs, T.P.3
Siris, E.4
Bilezikian, J.P.5
-
58
-
-
0042878414
-
Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism
-
Vestergaard P, Mosekilde L. Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism. BMJ. 2003;327:530-534.
-
(2003)
BMJ
, vol.327
, pp. 530-534
-
-
Vestergaard, P.1
Mosekilde, L.2
-
59
-
-
0030852304
-
Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure
-
DOI 10.1016/S0002-9343(97)00142-3, PII S0002934397001423
-
Shane E, Mancini D, Aaronson K, et al. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med. 1997;103:197-207. (Pubitemid 27413402)
-
(1997)
American Journal of Medicine
, vol.103
, Issue.3
, pp. 197-207
-
-
Shane, E.1
Mancini, D.2
Aaronson, K.3
Silverberg, S.J.4
Seibel, M.J.5
Addesso, V.6
McMahon, D.J.7
-
60
-
-
0142228231
-
Osteoporosis after solid organ and bone marrow transplantation
-
DOI 10.1007/s00198-003-1426-z
-
Cohen A, Shane E. Osteoporosis after solid organ and bone marrow transplantation. Osteoporos Int. 2003;14:617-630. (Pubitemid 41490345)
-
(2003)
Osteoporosis International
, vol.14
, Issue.8
, pp. 617-630
-
-
Cohen, A.1
Shane, E.2
-
61
-
-
8244247771
-
Bone loss and turnover after cardiac transplantation
-
Shane E, Rivas M, McMahon DJ, et al. Bone loss and turnover after cardiac transplantation. J Clin Endocrinol Metab. 1997;82:1497-1506. (Pubitemid 27200425)
-
(1997)
Journal of Clinical Endocrinology and Metabolism
, vol.82
, Issue.5
, pp. 1497-1506
-
-
Shane, E.1
Rivas, M.2
McMahon, D.J.3
Staron, R.B.4
Silverberg, S.J.5
Seibel, M.J.6
Mancini, D.7
Michler, R.E.8
Aaronson, K.9
Addesso, V.10
Lo, S.H.11
-
62
-
-
0035798944
-
Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: A follow-up study
-
DOI 10.1016/S0140-6736(00)03641-2
-
Leidig-Bruckner G, Hosch S, Dodidou P, et al. Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study. Lancet. 2001;357:342-347. (Pubitemid 32128540)
-
(2001)
Lancet
, vol.357
, Issue.9253
, pp. 342-347
-
-
Leidig-Bruckner, G.1
Hosch, S.2
Dodidou, P.3
Ritschel, D.4
Conradt, C.5
Klose, C.6
Otto, G.7
Lange, R.8
Theilmann, L.9
Zimmerman, R.10
Pritsch, M.11
Ziegler, R.12
-
63
-
-
35648988990
-
Post-Transplantation Osteoporosis
-
DOI 10.1016/j.ecl.2007.07.008, PII S0889852907000825, Endocrinopathies of Transplant Medicine
-
Stein E, Ebeling P, Shane E. Post-transplantation osteoporosis. Endocrinol Metab Clin N Am. 2007;36:937-963. (Pubitemid 350026259)
-
(2007)
Endocrinology and Metabolism Clinics of North America
, vol.36
, Issue.4
, pp. 937-963
-
-
Stein, E.1
Ebeling, P.2
Shane, E.3
-
64
-
-
84884559254
-
Incidence of fracture after cardiac and lung transplantation, a single center experience
-
Abstract
-
Hariman A, Alex C, Biljana-Palvoic, S, Heroux A, Camacho P. Incidence of fracture after cardiac and lung transplantation, a single center experience. In: Program of the 2011 Annual Meeting of ASBMR, September 16-20, 2011; Denver, Colorado. Abstract.
-
Program of the 2011 Annual Meeting of ASBMR, September 16-20, 2011; Denver, Colorado
-
-
Hariman, A.1
Alex, C.2
Biljana-Palvoic, S.3
Heroux, A.4
Camacho, P.5
-
65
-
-
0033979309
-
Altered bone metabolism in inflammatory bowel disease: There is a difference between Crohn's disease and ulcerative colitis
-
DOI 10.1046/j.1365-2796.2000.00582.x
-
Ardizzone S, Bollani S, Bettica P, Bevilacqua M, Molteni P, Bianchi Porro G. Altered bone metabolism in inflammatory bowel disease: There is a difference between Crohn's disease and ulcerative colitis. J Intern Med. 2000;247:63-70. (Pubitemid 30073165)
-
(2000)
Journal of Internal Medicine
, vol.247
, Issue.1
, pp. 63-70
-
-
Ardizzone, S.1
Bollani, S.2
Bettica, P.3
Bevilacqua, M.4
Molteni, P.5
Porro, G.B.6
-
66
-
-
0035133901
-
Osteoporosis in a North American adult population with celiac disease
-
DOI 10.1016/S0002-9270(00)02300-5, PII S0002927000023005
-
Meyer D, Stavropolous S, Diamond B, Shane E, Green PH. Osteoporosis in a North American adult population with celiac disease. Am J Gastroenterol. 2001;96:112-119. (Pubitemid 32104817)
-
(2001)
American Journal of Gastroenterology
, vol.96
, Issue.1
, pp. 112-119
-
-
Meyer, D.1
Stavropolous, S.2
Diamond, B.3
Shane, E.4
Green, P.H.R.5
-
67
-
-
14044258690
-
Increased prevalence of celiac disease and need for routine screening among patients with osteoporosis
-
DOI 10.1001/archinte.165.4.393
-
Stenson WF, Newberry R, Lorenz R, Baldus C, Civitelli R. Increased prevalence of celiac disease and need for routine screening among patients with osteoporosis. Arch Intern Med. 2005;165:393-399. (Pubitemid 40280193)
-
(2005)
Archives of Internal Medicine
, vol.165
, Issue.4
, pp. 393-399
-
-
Stenson, W.F.1
Newberry, R.2
Lorenz, R.3
Baldus, C.4
Civitelli, R.5
-
69
-
-
0029040649
-
A controlled study of bone mineral density in patients with inflammatory bowel disease
-
Silvennoinen JA, Karttunen TJ, Niemela SE, Manelius JJ, Lehtola JK. A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut. 1995;37:71-76.
-
(1995)
Gut
, vol.37
, pp. 71-76
-
-
Silvennoinen, J.A.1
Karttunen, T.J.2
Niemela, S.E.3
Manelius, J.J.4
Lehtola, J.K.5
-
70
-
-
78549261031
-
Endocrine and bone disease in appropriately treated adult patients with beta-thalassemia major
-
Baldini M, Forti, S. Endocrine and bone disease in appropriately treated adult patients with beta-thalassemia major. Ann Hematol. 2010;89:1207-1213.
-
(2010)
Ann Hematol
, vol.89
, pp. 1207-1213
-
-
Baldini, M.1
Forti, S.2
-
71
-
-
14344250737
-
Fracture risk with multiple myeloma: A population-based study
-
DOI 10.1359/JBMR.041131
-
Melton LJ III, Kyle RA, Achenbach SJ, Oberg AL, Rajkumar SV. Fracture risk with multiple myeloma: A population-based study. J Bone Miner Res. 2005;20:487-493. (Pubitemid 40293498)
-
(2005)
Journal of Bone and Mineral Research
, vol.20
, Issue.3
, pp. 487-493
-
-
Melton III, L.J.1
Kyle, R.A.2
Achenbach, S.J.3
Oberg, A.L.4
Rajkumar, S.V.5
-
72
-
-
77957960294
-
Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: A population-based study
-
Kristinsson SY, Tang M, Pfeiffer RM, et al. Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study. Blood. 2010;116:2651-2655.
-
(2010)
Blood
, vol.116
, pp. 2651-2655
-
-
Kristinsson, S.Y.1
Tang, M.2
Pfeiffer, R.M.3
-
73
-
-
27644433080
-
Cortisol secretion and rate of bone loss in a population-based cohort of elderly men and women
-
DOI 10.1007/s00223-004-0270-2
-
Reynolds RM, Dennison EM, Walker BR, et al. Cortisol secretion and rate of bone loss in a population-based cohort of elderly men and women. Calcif Tissue Int. 2005;77:134-138. (Pubitemid 41569742)
-
(2005)
Calcified Tissue International
, vol.77
, Issue.3
, pp. 134-138
-
-
Reynolds, R.M.1
Dennison, E.M.2
Walker, B.R.3
Syddall, H.E.4
Wood, P.J.5
Andrew, R.6
Phillips, D.I.7
Cooper, C.8
-
74
-
-
0037236628
-
Does subclinical hypercortisolism adversely affect the bone mineral density of patients with adrenal incidentalomas?
-
DOI 10.1046/j.1365-2265.2003.01676.x
-
Hadjidakis D, Tsagarakis S, Roboti C, et al. Does subclinical hypercortisolism adversely affect the bone mineral density of patients with adrenal incidentalomas? Clin Endocrinol (Oxf). 2003;58:72-77. (Pubitemid 36098851)
-
(2003)
Clinical Endocrinology
, vol.58
, Issue.1
, pp. 72-77
-
-
Hadjidakis, D.1
Tsagarakis, S.2
Roboti, C.3
Sfakianakis, M.4
Iconomidou, V.5
Raptis, S.A.6
Thalassinos, N.7
-
75
-
-
35848965736
-
Subclinical hypercortisolism among outpatients referred for osteoporosis
-
Chiodini I, Mascia ML, Muscarella S, et al. Subclinical hypercortisolism among outpatients referred for osteoporosis. Ann Int Med. 2007;147:541-548. (Pubitemid 351664501)
-
(2007)
Annals of Internal Medicine
, vol.147
, Issue.8
, pp. 541-548
-
-
Chiodini, I.1
Mascia, M.L.2
Muscarella, S.3
Battista, C.4
Minisola, S.5
Arosio, M.6
Santini, S.A.7
Guglielmi, G.8
Carnevale, V.9
Scillitani, A.10
-
76
-
-
0028857530
-
Ambulatory evaluation of nephrolithiasis: An update of a 1980 protocol
-
Levy FL, Adams-Huet B, Pak CY. Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med. 1995;98:50-59.
-
(1995)
Am J Med
, vol.98
, pp. 50-59
-
-
Levy, F.L.1
Adams-Huet, B.2
Pak, C.Y.3
-
78
-
-
0036094023
-
Bone alterations in patients with idiopathic hypercalciuria and calcium nephrolithiasis
-
DOI 10.1016/S0090-4295(02)01626-6, PII S0090429502016266
-
Tasca A, Cacciola A, Ferrarese P, et al. Bone alterations in patients with idiopathic hypercalciuria and calcium nephrolithiasis. Urology. 2002;59:865-869. (Pubitemid 34522177)
-
(2002)
Urology
, vol.59
, Issue.6
, pp. 865-869
-
-
Tasca, A.1
Cacciola, A.2
Ferrarese, P.3
Ioverno, E.4
Visona, E.5
Bernardi, C.6
Nobile, M.7
Giannini, S.8
-
79
-
-
0036197001
-
Bone involvement in idiopathic hypercalciuria
-
Misael da Silva AM, dos Reis LM, Pereira RC, et al. Bone involvement in idiopathic hypercalciuria. Clin Nephrol. 2002;57:183-191. (Pubitemid 34213656)
-
(2002)
Clinical Nephrology
, vol.57
, Issue.3
, pp. 183-191
-
-
Misael Da, S.A.M.1
Dos, R.L.M.2
Pereira, R.C.3
Futata, E.4
Branco-Martins, C.T.5
Noronha, I.L.6
Wajchemberg, B.L.7
Jorgetti, V.8
-
80
-
-
0141797417
-
Thiazide diuretics and the risk for hip fracture
-
Mariette W, Schoofs C, Hofman A, et al. Thiazide diuretics and the risk for hip fracture. Ann Intern Med. 2003;139:476-482.
-
(2003)
Ann Intern Med
, vol.139
, pp. 476-482
-
-
Mariette, W.1
Schoofs, C.2
Hofman, A.3
|